In June 2023, RANZCP introduced a clinical memorandum “Therapeutic Usage of copyright Substances”. The purpose of the memo was to tell psychiatrists with regard to the opportunity therapeutic usage of copyright substances to support the treatment of mental illness. When selecting a pr